ampicillin has been researched along with carbapenems in 42 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (4.76) | 18.7374 |
| 1990's | 3 (7.14) | 18.2507 |
| 2000's | 8 (19.05) | 29.6817 |
| 2010's | 23 (54.76) | 24.3611 |
| 2020's | 6 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Castellani, P; Della Bruna, C; Meinardi, G | 1 |
| Powell, M; Seetulsingh, P; Williams, JD | 1 |
| Edwards, JR; Nairn, K; Shepherd, GL | 1 |
| Livermore, DM; Yuan, M | 1 |
| Verbist, L; Verhaegen, J | 1 |
| Frère, JM; Galleni, M; Matagne, A; Solmajer, T; Turk, B; Vilar, M | 1 |
| Powell, LL; Wilson, SE | 1 |
| Chang, CY; Chang, YL; Hsu, CK; Hsueh, PR; Kuo, LC; Lai, CC; Liao, CH | 1 |
| Cassone, A; Di Sora, F; Dionisi, AM; Gallo, S; Longo, B; Luzzi, I; Monaco, M; Montella, F; Pantosti, A; Placanica, P; Rezza, G; Tarasi, A; Volpe, I | 1 |
| Durante-Mangoni, E; Fortunato, R; Tripodi, MF; Utili, R; Zarrilli, R | 1 |
| Ida, T; Kato, Y; Maebashi, K; Sanbongi, Y; Takahata, S | 1 |
| Costa, SF; Grinbaum, RS; Levin, AS; Oliveira, MS; Prado, GV | 1 |
| Akita, H; Chiba, N; Hasegawa, K; Iwata, S; Nonoyama, M; Sato, Y; Sunakawa, K; Ubukata, K | 1 |
| dos Santos, RP; Goldani, LZ; Jacoby, T | 1 |
| Hagihara, M; Housman, ST; Kuti, JL; Nicolau, DP | 1 |
| Costa, SF; Levin, AS; Oliveira, MS; Pedri, Ed; van der Heijden, I | 1 |
| Hiraki, Y; Inoue, D; Kamimura, H; Karube, Y; Kawano, F; Masuda, Y; Takaki, K; Tsuji, Y; Yoshida, M | 1 |
| Bonomo, RA; June, CM; Kaitany, KC; Klinger, NV; Leonard, DA; Powers, RA; Ramey, ME | 1 |
| Ahmed, H; Awali, RA; Chaudary, K; Chopra, T; Hothi, J; Johnson, P; Kaye, KS; Krishna, A; Lephart, P; Marchaim, D; Pogue, JM; Slim, J; Tansek, R; Zhao, JJ | 1 |
| Ferreira, TP; Gobbi, DD; Hofer, E; Matté, GR; Matté, MH; Moreno, AM; Moreno, LZ; Paixão, R; Raimundo, DC; Reis, CM | 1 |
| Chen, S; Chiou, J; Leung, TY | 1 |
| Wu, H; Xie, W; Ye, Z; Zhang, W; Zhao, C | 1 |
| Leonard, DA; Mitchell, JM | 1 |
| Doi, Y; Ernst, RK; Hittle, LE; O'Hara, JA; Pasculle, AW; Qureshi, ZA; Rivera, JI; Shields, RK; Syed, A | 1 |
| Cheng, CW; Hsu, PC; Huang, CT; Lee, MH; Leu, HS; Lin, HS; Ye, JJ | 1 |
| Caballero, S; Carter, R; Ke, X; Kim, GJ; Leiner, IM; Ling, L; Manova, K; Miller, L; Pamer, EG; Sušac, B | 1 |
| Kollef, MH; Shorr, AF; Zilberberg, MD | 1 |
| Barišić, Z; Goic-Barisic, I; Hrenović, J; Kaliterna, M; Kaliterna, V; Tonkić, M | 1 |
| Fujiya, Y; Hayakawa, K; Kutsuna, S; Mawatari, M; Mezaki, K; Nagamatsu, M; Ohmagari, N; Takeshita, N; Tamura, S; Yamamoto, K | 1 |
| Huang, J; Li, J; Liu, Q; Lu, T; Ren, J; Wang, G; Wang, Z; Wu, J; Wu, X | 1 |
| Arthur, M; Edoo, Z; Hugonnet, JE; Mainardi, JL; Sütterlin, L | 1 |
| Abdollahi, A; Beigmohammadi, MT; Doomanlou, M; Khalili, H; Mohammadi, M; Shojaei, L | 1 |
| Hu, L; Palzkill, T; Prasad, BVV; Sankaran, B; Sun, Z | 1 |
| Abdelgani, S; Amir-Ronen, R; Geffen, Y; Liron, Y; Ohanyan, A; Paul, M; Raz-Pasteur, A | 1 |
| Adachi, Y; Iwata, S; Mokuno, E; Morozumi, M; Sakuma, M; Tajima, T; Ubukata, K | 1 |
| Babaie, Z; Delfani, S; Mahdian, S; Norolahi, F; Rezaei, F; Shakib, P | 1 |
| Demir, M; Kazanasmaz, H | 1 |
| Antunes, VU; Doucet, N; Farah, CS; Favaro, DC; Lincopan, N; Llontop, EE; López de Los Santos, Y; Mittermaier, A; Oliveira, RJ; Vasconcelos, FNDC | 1 |
| Jeyakanthan, J; Lopes, BS; Ramachandran, B | 1 |
| Academia, EC; Jenrette, JE; McLaughlin, JM; Mueller, SW | 1 |
| Gehlot, P; P, H | 1 |
| Acman, M; Chiu, CH; Hamawandi, A; Lindsay, JA; Readman, JB; Sharland, M; Standing, JF | 1 |
1 review(s) available for ampicillin and carbapenems
| Article | Year |
|---|---|
The role of beta-lactam antimicrobials as single agents in treatment of intra-abdominal infection.
Topics: Abdomen; Abdominal Abscess; Ampicillin; Anti-Bacterial Agents; Bacterial Infections; beta-Lactamase Inhibitors; Carbapenems; Cephalosporins; Clavulanic Acids; Drug Resistance, Bacterial; Drug Therapy, Combination; Enzyme Inhibitors; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam; Surgical Wound Infection; Ticarcillin | 2000 |
1 trial(s) available for ampicillin and carbapenems
| Article | Year |
|---|---|
Meropenem/colistin versus meropenem/ampicillin-sulbactam in the treatment of carbapenem-resistant pneumonia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Ampicillin; Anti-Bacterial Agents; Carbapenems; Colistin; Drug Combinations; Drug Resistance, Bacterial; Female; Humans; Male; Meropenem; Middle Aged; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Sulbactam | 2018 |
40 other study(ies) available for ampicillin and carbapenems
| Article | Year |
|---|---|
Activity of FCE 22101 and other beta-lactam antibiotics against experimental genital infections in the rat and mouse.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Cefuroxime; Female; Genital Diseases, Female; Mice; Rats; Surgical Wound Infection; Uterine Diseases; Uterus | 1989 |
In-vitro susceptibility of Haemophilus influenzae to meropenem compared with imipenem, five other beta-lactams, chloramphenicol and ciprofloxacin.
Topics: Ampicillin; Anti-Bacterial Agents; Carbapenems; Chloramphenicol; Ciprofloxacin; Culture Media; Haemophilus influenzae; Imipenem; Meropenem; Microbial Sensitivity Tests; Penicillin Resistance; Thienamycins | 1989 |
Efficacy of meropenem in experimental meningitis.
Topics: Ampicillin; Animals; Carbapenems; Ceftazidime; Ceftriaxone; Cephalosporins; Cerebrospinal Fluid; Cerebrospinal Fluid Proteins; Drug Evaluation; Drug Resistance, Microbial; Escherichia coli Infections; Gentamicins; Guinea Pigs; Haemophilus Infections; Haemophilus influenzae; Listeriosis; Meningitis, Bacterial; Meropenem; Neisseria meningitidis; Penicillin G; Pneumococcal Infections; Thienamycins | 1995 |
Antibiotic resistance and production of extended-spectrum beta-lactamases amongst Klebsiella spp. from intensive care units in Europe.
Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Ceftazidime; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Drug Therapy, Combination; Enzyme Inhibitors; Europe; Humans; Intensive Care Units; Klebsiella; Klebsiella Infections; Microbial Sensitivity Tests; Monobactams; Penicillanic Acid; Piperacillin; Tazobactam | 1996 |
In-vitro activity of 21 beta-lactam antibiotics against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae.
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cefaclor; Cefadroxil; Cefatrizine; Cefepime; Cefixime; Cefotaxime; Cefpirome; Cefpodoxime; Ceftazidime; Ceftibuten; Ceftizoxime; Ceftriaxone; Cefuroxime; Cephalosporins; Cephradine; Drug Resistance, Microbial; Drug Resistance, Multiple; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Piperacillin; Pneumococcal Infections; Serotyping; Species Specificity; Streptococcus pneumoniae | 1998 |
Kinetic study of two novel enantiomeric tricyclic beta-lactams which efficiently inactivate class C beta-lactamases.
Topics: Ampicillin; beta-Lactamase Inhibitors; Carbapenems; Drug Interactions; Enterobacter cloacae; Enzyme Inhibitors; Kinetics; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Penicillins; Streptomyces; Structure-Activity Relationship; Substrate Specificity | 2001 |
Multidrug-resistant Acinetobacter baumannii bacteraemia: clinical features, antimicrobial therapy and outcome.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Ampicillin; Anti-Bacterial Agents; Bacteremia; Carbapenems; Drug Resistance, Multiple, Bacterial; Female; Fluoroquinolones; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Sulbactam; Treatment Outcome | 2007 |
Molecular findings and antibiotic-resistance in an outbreak of Acinetobacter baumannii in an intensive care unit.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Bronchoalveolar Lavage Fluid; Carbapenems; Colistin; Cross Infection; Disease Outbreaks; Disinfection; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Humans; Intensive Care Units; Male; Middle Aged; Patient Isolation; Rifampin; Rome; Sulbactam | 2007 |
Comparative activities of colistin, rifampicin, imipenem and sulbactam/ampicillin alone or in combination against epidemic multidrug-resistant Acinetobacter baumannii isolates producing OXA-58 carbapenemases.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Ampicillin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Drug Synergism; Electrophoresis, Gel, Pulsed-Field; Humans; Imipenem; Italy; Microbial Sensitivity Tests; Rifampin; Sulbactam | 2007 |
Comparison of the efficacies of oral beta-lactams in selection of Haemophilus influenzae transformants with mutated ftsI genes.
Topics: Ampicillin; Bacterial Proteins; beta-Lactams; Carbapenems; Cefdinir; Cefprozil; Cephalosporins; Gene Transfer, Horizontal; Haemophilus influenzae; Mutation; Penicillin-Binding Proteins | 2008 |
Ampicillin/sulbactam compared with polymyxins for the treatment of infections caused by carbapenem-resistant Acinetobacter spp.
Topics: Acinetobacter; Acinetobacter Infections; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Ampicillin; APACHE; beta-Lactam Resistance; Bronchoalveolar Lavage Fluid; Carbapenems; Child; Child, Preschool; Cross Infection; Female; Hospitals, Teaching; Humans; Infant; Logistic Models; Male; Middle Aged; Multivariate Analysis; Polymyxins; Prognosis; Renal Insufficiency; Retrospective Studies; Risk Factors; Shock, Septic; Sulbactam; Time Factors; Treatment Outcome | 2008 |
[Childhood bacterial meningitis trends in Japan from 2005 to 2006].
Topics: Adolescent; Age Distribution; Ampicillin; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cephalosporins; Child; Child, Preschool; Drug Resistance; Drug Therapy, Combination; Escherichia coli; Female; Haemophilus influenzae; Humans; Infant; Infant, Newborn; Japan; Male; Meningitis, Bacterial; Streptococcus pneumoniae; Time Factors | 2008 |
Antimicrobial stewardship lessons: do Pseudomonas-sparing agents, such as ertapenem, effectively improve bacterial resistance?
Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Ertapenem; Humans; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Sulbactam | 2010 |
In vitro pharmacodynamics of human-simulated exposures of ampicillin/sulbactam, doripenem and tigecycline alone and in combination against multidrug-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Ampicillin; Anti-Bacterial Agents; Bacterial Load; Carbapenems; Doripenem; Drug Combinations; Drug Resistance, Multiple, Bacterial; Humans; In Vitro Techniques; Minocycline; Models, Theoretical; Sulbactam; Tigecycline | 2013 |
The minimal inhibitory concentration for sulbactam was not associated with the outcome of infections caused by carbapenem-resistant Acinetobacter sp. treated with ampicillin/sulbactam.
Topics: Acinetobacter; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Child; Female; Hospital Mortality; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Sulbactam; Treatment Outcome; Young Adult | 2013 |
Successful treatment of skin and soft tissue infection due to carbapenem-resistant Acinetobacter baumannii by ampicillin-sulbactam and meropenem combination therapy.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Ampicillin; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Drug Therapy, Combination; Female; Humans; Meropenem; Microbial Sensitivity Tests; Skin Diseases, Bacterial; Soft Tissue Infections; Sulbactam; Thienamycins; Treatment Outcome | 2013 |
Structures of the class D Carbapenemases OXA-23 and OXA-146: mechanistic basis of activity against carbapenems, extended-spectrum cephalosporins, and aztreonam.
Topics: Acinetobacter; Amino Acid Sequence; Ampicillin; Anti-Bacterial Agents; Aztreonam; Bacterial Proteins; beta-Lactamases; Carbapenems; Cephalosporins; Crystallography, X-Ray; Doripenem; Microbial Sensitivity Tests; Molecular Sequence Data; Sequence Homology, Amino Acid | 2013 |
Epidemiology of bloodstream infections caused by Acinetobacter baumannii and impact of drug resistance to both carbapenems and ampicillin-sulbactam on clinical outcomes.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Carbapenems; Drug Resistance, Multiple, Bacterial; Humans; Michigan; Middle Aged; Retrospective Studies; Sulbactam | 2013 |
Characterization of antibiotic resistance in Listeria spp. isolated from slaughterhouse environments, pork and human infections.
Topics: Abattoirs; Ampicillin; Animals; Anti-Bacterial Agents; Carbapenems; Clindamycin; Daptomycin; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Erythromycin; Fluoroquinolones; Genes, Bacterial; Humans; Listeria; Microbial Sensitivity Tests; Oxacillin; Swine; Tetracycline | 2014 |
Molecular mechanisms of substrate recognition and specificity of New Delhi metallo-β-lactamase.
Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Catalytic Domain; Cephalosporins; Hydrolysis; Hydrophobic and Hydrophilic Interactions; Microbial Sensitivity Tests; Substrate Specificity | 2014 |
[Mechanism of drug resistance of carbapenems-resistant Acinetobacter baumannii and the application of a combination of drugs in vitro].
Topics: Acinetobacter baumannii; Acinetobacter Infections; Ampicillin; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Carbapenems; Cefepime; Cephalosporins; Drug Resistance; Humans; In Vitro Techniques; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Pharmaceutical Preparations; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam; Thienamycins | 2014 |
Common clinical substitutions enhance the carbapenemase activity of OXA-51-like class D β-lactamases from Acinetobacter spp.
Topics: Acinetobacter; Acinetobacter Infections; Ampicillin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Catalytic Domain; Cross Infection; Humans; Protein Folding | 2014 |
Colistin-resistant Acinetobacter baumannii: beyond carbapenem resistance.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Ampicillin; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Electronic Health Records; Electrophoresis, Gel, Pulsed-Field; Ethanolamines; Female; Humans; Lipid A; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Pneumonia, Ventilator-Associated; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Sulbactam | 2015 |
Sulbactam treatment for pneumonia involving multidrug-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex.
Topics: Acinetobacter baumannii; Acinetobacter calcoaceticus; Acinetobacter Infections; Adult; Aged; Ampicillin; Anti-Bacterial Agents; Carbapenems; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Bacterial; Retrospective Studies; Sulbactam; Taiwan; Time Factors | 2015 |
Distinct but Spatially Overlapping Intestinal Niches for Vancomycin-Resistant Enterococcus faecium and Carbapenem-Resistant Klebsiella pneumoniae.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Carbapenems; Colony Count, Microbial; Drug Resistance, Bacterial; Enteritis; Enterococcus faecium; Fecal Microbiota Transplantation; Feces; Female; Gastrointestinal Microbiome; Gram-Positive Bacterial Infections; Host-Pathogen Interactions; In Situ Hybridization, Fluorescence; Intestinal Mucosa; Klebsiella Infections; Klebsiella pneumoniae; Mice, Inbred C57BL; Microbial Interactions; Specific Pathogen-Free Organisms; Vancomycin-Resistant Enterococci | 2015 |
Secular trends in Acinetobacter baumannii resistance in respiratory and blood stream specimens in the United States, 2003 to 2012: A survey study.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Ampicillin; Anti-Bacterial Agents; Bacteremia; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Humans; Intensive Care Units; Microbial Sensitivity Tests; Respiratory Tract Infections; Sulbactam; Surveys and Questionnaires; Trimethoprim, Sulfamethoxazole Drug Combination; United States | 2016 |
Acinetobacter baumannii in Southern Croatia: clonal lineages, biofilm formation, and resistance patterns.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Ampicillin; Anti-Bacterial Agents; Biofilms; Carbapenems; Croatia; Cross Infection; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Genotype; Humans; Intensive Care Units; Microbial Sensitivity Tests; Monte Carlo Method; Respiratory System; Respiratory Tract Infections; Sulbactam; Urine; Wounds and Injuries | 2015 |
Bacteremia Due to Arthrobacter creatinolyticus in an Elderly Diabetic Man with Acute Cholangitis.
Topics: Aerobiosis; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Arthrobacter; Bacteremia; beta-Lactamase Inhibitors; Carbapenems; Cholangitis; Diabetes Complications; DNA, Bacterial; DNA, Ribosomal; Doripenem; Gram-Positive Bacterial Infections; Humans; Male; RNA, Ribosomal, 16S; Sequence Analysis, DNA; Sulbactam | 2017 |
Shifting trends in bacteriology and antimicrobial resistance among gastrointestinal fistula patients in China: an eight-year review in a tertiary-care hospital.
Topics: Adolescent; Adult; Aged; Ampicillin; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; China; Digestive System Fistula; Drug Resistance, Bacterial; Escherichia coli; Female; Gram-Negative Bacteria; Humans; Imipenem; Intraabdominal Infections; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Young Adult | 2017 |
Peptidoglycan Cross-Linking Activity of l,d-Transpeptidases from Clostridium difficile and Inactivation of These Enzymes by β-Lactams.
Topics: Acylation; Ampicillin; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Clostridioides difficile; Hydrolysis; Mass Spectrometry; Peptidoglycan; Peptidyl Transferases | 2018 |
Differential active site requirements for NDM-1 β-lactamase hydrolysis of carbapenem versus penicillin and cephalosporin antibiotics.
Topics: Ampicillin; beta-Lactamases; Carbapenems; Catalytic Domain; Cefotaxime; Cephalosporins; Codon; Drug Resistance, Bacterial; Escherichia coli; High-Throughput Nucleotide Sequencing; Imipenem; Mutation; Penicillins | 2018 |
Trimethoprim-sulfamethoxazole vs. colistin or ampicillin-sulbactam for the treatment of carbapenem-resistant Acinetobacter baumannii: A retrospective matched cohort study.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Ampicillin; Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Female; Humans; Male; Middle Aged; Retrospective Studies; Shock, Septic; Sulbactam; Trimethoprim, Sulfamethoxazole Drug Combination | 2019 |
Genetic characteristics and antibiotic resistance of Haemophilus influenzae isolates from pediatric patients with acute otitis media after introduction of 13-valent pneumococcal conjugate vaccine in Japan.
Topics: Acute Disease; Ampicillin; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cephalosporins; Child, Preschool; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Haemophilus Infections; Haemophilus influenzae; Humans; Infant; Japan; Microbial Sensitivity Tests; Multilocus Sequence Typing; Naphthyridines; Otitis Media; Pneumococcal Vaccines; Quinolones; Streptococcus pneumoniae; Vaccines, Conjugate | 2019 |
Molecular Detection of Carbapenem Resistance in Acinetobacter Baumannii Isolated From Patients in Khorramabad City, Iran.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Ampicillin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Cross-Sectional Studies; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Iran; Microbial Sensitivity Tests; Sulbactam | 2020 |
Uropathogens and antibiotic resistance in the community and hospital-induced urinary tract infected children.
Topics: Adolescent; Amikacin; Ampicillin; Anti-Bacterial Agents; Carbapenems; Child; Child, Preschool; Drug Resistance, Bacterial; Escherichia coli; Female; Humans; Infant; Infant, Newborn; Inpatients; Klebsiella; Male; Microbial Sensitivity Tests; Outpatients; Proteus; Retrospective Studies; Trimethoprim, Sulfamethoxazole Drug Combination; Turkey; Urinary Tract Infections | 2020 |
Importance of the β5-β6 Loop for the Structure, Catalytic Efficiency, and Stability of Carbapenem-Hydrolyzing Class D β-Lactamase Subfamily OXA-143.
Topics: Acinetobacter baumannii; Ampicillin; Aztreonam; beta-Lactamases; Carbapenems; Ceftazidime; Hydrolysis; Kinetics; Models, Molecular; Molecular Dynamics Simulation; Mutation, Missense; Oxacillin; Protein Conformation, beta-Strand; Protein Stability; Substrate Specificity | 2019 |
Molecular docking, dynamics and free energy analyses of
Topics: Acinetobacter baumannii; Ampicillin; beta-Lactamases; Carbapenems; Catalytic Domain; Computer Simulation; Doripenem; Ertapenem; Hydrolysis; Meropenem; Molecular Conformation; Molecular Docking Simulation; Molecular Dynamics Simulation | 2020 |
Evaluation of First-Dose, Intravenous Push Penicillins and Carbapenems in the Emergency Department.
Topics: Ampicillin; Anti-Bacterial Agents; Carbapenems; Emergency Service, Hospital; Ertapenem; Humans; Penicillins; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Sulbactam | 2022 |
Computational and data mining studies to understand the distribution and dynamics of Temoneria (TEM) β-lactamase and their interaction with β-lactam and β-lactamase inhibitors.
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Data Mining; Molecular Docking Simulation; Monobactams; Penicillins; Tazobactam | 2022 |
Cefotaxime/sulbactam plus gentamicin as a potential carbapenem- and amikacin-sparing first-line combination for neonatal sepsis in high ESBL prevalence settings.
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cefotaxime; Escherichia coli; Gentamicins; Humans; Infant, Newborn; Microbial Sensitivity Tests; Neonatal Sepsis; Prevalence; Sulbactam | 2023 |